Laser therapy shows promise for chronic Bell's palsy
NCT ID NCT05846217
First seen Jun 22, 2026 · Last updated Jun 22, 2026
Summary
This study tested a special laser device (Multiwave Locked System) on 84 adults with Bell's palsy that had lasted more than 8 weeks. Participants received laser treatment three times a week for six months. The goal was to see if the laser could improve facial movement and reduce symptoms. The trial compared the real laser to a sham treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BELL'S PALSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing TongRen Hospital, Capital Medical University
Beijing, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Multiwave Locked System laser (class IV NIR laser device)
What this could lead to
If it works, this could offer a non-drug treatment option for people with long-lasting Bell's palsy to improve facial function.
What could go wrong
This is a small, single-center trial with only 84 participants. The results may not apply to everyone, and the laser device is not widely available.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.